Sin conexión a internet: se muestra la versión guardada de la página.

Elevance Health I…

USUSD
← Al Screener

Elevance Health Inc (LSE:0HG8) — Medical Specialities. Número de bolsas en las que cotizan las acciones de la empresa: 2. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.

Sobre la Empresa

Sitio Web
elevancehealth.com
Relaciones con los Inversores
ir.elevancehealth.com/
Sector
Health Care · Medical Specialities
Sede Central
Indianapolis, United States
Gestión
Gail Boudreaux
Últimos Informes
anual 2025 ELEVANCE HEALTH INC 10K BOOKMARK 2026 VFINAL
Empleados
96 129
Fundada
1940
Acciones en Circulación
216.06 M a 2026-10-15
FechaAccionesCambio
15.10.2026216.06 M−0.4%recompra
10.07.2026216.87 M
Número de acciones según los informes de la empresa. Un split se detecta por un salto del número en un múltiplo entero.
Capital Flotante
216.37 M
Capitalización Bursátil
85.17 mil M USD
Insiders
0.19%
Inversores Institucionales
94.15%
Industria (SIC)
Hospital & Medical Service Plans
Forma Jurídica
R0BI
ISIN
US0367521038
LEI
8MYN82XMYQH89CTMTH67
P/E
15.6
P/B
2.13
Ratio de Reparto
29.2%
FCF
6.51 mil M USD
Pagos / FCF
23%
Deuda
30.8 mil M USD
3.1 a. de FCF
Racha de Dividendos
15 a.
Beneficios, FCF y dividendos pagados — para los 12 meses hasta 30.09.2026 (el último informe de la compañía).
NAV
207 USD · P/NAV 1.92
Fecha del Balance30.09.2026
Activos128 mil M USD
− Pasivos83.0 mil M USD
= Patrimonio Total44.8 mil M USD
− Participaciones No Dominantes113 M USD
= NAV (patrimonio de los accionistas de la empresa)44.7 mil M USD
− Fondo de Comercio28.3 mil M USD
− Activos Intangibles10.9 mil M USD
= NAV Tangible5.46 mil M USD
Acciones216 113 946
NAV por Acción207 USD
NAV Tangible por Acción25.27 USD
Precio de la Acción (0HG8)396.73 USD
P/NAV1.92
Historial del NAV
Fecha del BalanceNAVNAV por Acción
30.09.202644.7 mil M USD207 USD
30.06.202644.9 mil M USD207 USD
31.03.202643.9 mil M USD202 USD
31.12.202543.9 mil M USD199 USD
30.09.202544.0 mil M USD198 USD
30.06.202543.7 mil M USD194 USD
31.03.202542.5 mil M USD188 USD
31.12.202441.3 mil M USD182 USD
Descripción

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

anuncio

Bolsas y Tickers

BolsaTickerMonedaPrecioTipo
US USA StocksELV principalUSD439.95 -1.20%acciones ordinarias
LSE London Stock Exchange0HG8 IOBUSD396.73 +0.00%acciones ordinarias

Precio en 3 Meses

día alcista día bajista fecha ex-dividendo fecha de pagoPasa el cursor / toca un día — precios de apertura, cierre, máximo y mínimo

Dividendos

Próxima fecha ex: 2026-12-04 · 1.72 USD (US:ELV)
Por año, US:ELV: 6.88 USD (4 pagos)

Elevance Health Inc (ELV) paga dividendos trimestralmente. Por año (12 meses hasta e incluyendo el último pago anunciado): 6.88 USD por acción (pagos: 4). Eso representa aproximadamente el 1.56% del precio actual de la acción. La próxima fecha ex-dividendo es el 04.12.2026: 1.72 USD por acción, con pago el 18.12.2026. Historial de dividendos ininterrumpido: 15 años.

Fecha ExPagoImporte%TipoTicker
2026-12-04 anunciado2026-12-181.7200 USD0.4/1.6 %trimestralUS:ELV
2026-09-102026-09-251.7200 USD0.4/1.7 %trimestralUS:ELV
2026-06-102026-06-251.7200 USD0.4/1.6 %trimestralUS:ELV
2026-03-102026-03-251.7200 USD0.6/2.4 %trimestralUS:ELV
2025-12-052025-12-191.7100 USD0.5/2.1 %trimestralUS:ELV
2025-09-102025-09-251.7100 USD0.5/2.1 %trimestralUS:ELV
2025-06-102025-06-251.7100 USD0.4/1.7 %trimestralUS:ELV
2025-03-102025-03-251.7100 USD0.4/1.6 %trimestralUS:ELV
2024-12-052024-12-201.6300 USD0.4/1.6 %trimestralUS:ELV
2024-09-102024-09-251.6300 USD0.4/1.4 %trimestralUS:ELV
2024-06-102024-06-251.6300 USD0.4/1.4 %trimestralUS:ELV
2024-03-072024-03-221.6300 USD0.4/1.4 %trimestralUS:ELV
2023-12-052023-12-211.4800 USD0.3/1.3 %trimestralUS:ELV
2023-09-072023-09-221.4800 USD0.3/1.3 %trimestralUS:ELV
2023-06-082023-06-231.4800 USD0.3/1.3 %trimestralUS:ELV
2023-03-092023-03-241.4800 USD0.3/1.2 %trimestralUS:ELV
2022-12-022022-12-211.2800 USD0.3/1.2 %trimestralUS:ELV
2022-09-082022-09-231.2800 USD0.3/1.1 %trimestralUS:ELV
2022-06-092022-06-241.2800 USD0.3/0.8 %trimestralUS:ELV
2022-03-092022-03-251.2800 USD0.3/0.5 %trimestralUS:ELV
2021-12-022021-12-211.1300 USD0.3/0.3 %trimestralUS:ELV

Noticias de Esta Semana

Comunicados de prensa desde la página web para inversores de la empresa, actualizados diariamente. Los enlaces conducen a la página web de la empresa. Los titulares están en el idioma original, como en la página web de la empresa.

Principales Accionistas

TitularParticipaciónAccionesFecha del Informe
Blackrock Inc.8.76%18.99 M2026-06-30
Vanguard Capital Managem…6.48%14.06 M2026-06-30
State Street Corporation4.81%10.43 M2026-06-30
Wellington Management Gr…4.25%9.21 M2026-06-30
VANGUARD INDEX FUNDS-Van…3.05%6.61 M2026-06-30
Vanguard Portfolio Manag…2.87%6.21 M2026-06-30
Sanders Capital, LLC2.69%5.83 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.49%5.39 M2026-06-30
Geode Capital Management…2.38%5.17 M2026-06-30
Harris Associates L.P.2.27%4.92 M2026-06-30
Artisan Partners Limited…2.11%4.58 M2026-06-30
Invesco Ltd.1.95%4.23 M2026-06-30
VANGUARD WINDSOR FUNDS-V…1.4%3.04 M2026-07-31
iShares Trust-iShares Co…1.33%2.89 M2026-08-31
First Eagle Funds-First…1.31%2.84 M2026-07-31
Fidelity Concord Street…1.29%2.81 M2026-07-31
SPDR S&P 500 ETF TRUST-S…1.23%2.66 M2026-08-31
VANGUARD FENWAY FUNDS-Va…0.94%2.05 M2026-06-30
VANGUARD INDEX FUNDS-Van…0.93%2.02 M2026-06-30
VANGUARD SPECIALIZED FUN…0.86%1.86 M2026-07-31
BOUDREAUX GAIL A KOZIARA…≈0.08%172 0362026-07-17
BOUDREAUX GAIL KOZIARA (…≈0.08%169 3112026-03-02
NORWOOD FELICIA F. (Offi…≈0.02%38 8382026-03-02
KAYE MARK (Chief Financi…≈0.01%32 0372026-03-02
HAYTAIAN PETER D (Office…≈0.01%27 2222026-03-02
LAVU RATNAKAR (Chief Tec…≈0.01%16 1492026-03-02
HAY LEWIS III (Director)≈0.01%12 0702026-05-13
KENDRICK CHARLES MORGAN…≈0.01%11 7912026-03-06
PERU RAMIRO G (Director)≈0.01%10 9082026-07-17
DIXON ROBERT L JR (Direc…≈0%10 7342026-06-11